Dr James Galloway

Dr Galloway is an academic rheumatologist at King’s College London. His research group is active in clinical trials, pharmacovigilance studies and large scale observational cohorts.

He has been actively involved in the COVID-19 response providing clinical care as well as developing the risk prediction model embedded into TACTIC.